CHROMOCELL THERAPEUTICS CORPORATION

Andere Sprachen Chromocell Therapeutics Corporation

Aktien

A3DXS6

US1711261057

CHRO

Markt geschlossen - Nyse Andere Börsenplätze 22:10:00 17.05.2024			% 5 Tage	% 1. Jan.
1,75 ^USD	-12,94 %		-1,13 %	0,00 %

15.05.	Chromocell Therapeutics Corporation meldet Ergebnis für das erste Quartal zum 31. März 2024	CI
16.04.	Chromocell Therapeutics Corporation berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Chromocell Therapeutics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	15.05.
Chromocell To Present at Alliance Global Partner’s Healthcare Company Showcase on Tuesday, May 21, 2024	13.05.
Chromocell To Present at Alliance Global Partner’s Healthcare Company Showcase on Tuesday, May 21, 2024	13.05.
Chromocell Therapeutics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	16.04.
Chromocell Issues Letter to Stockholders from Chief Executive Officer	09.04.
Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler	21.03.
Chromocell Therapeutics Corporation Announces Formal Launch of Eye Pain Treatment Program	21.03.
Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023	18.03.
Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023	18.03.
Chromocell Therapeutics Corp. Appoints Frank Knuettel, Interim CEO, as Permanent CEO	18.03.
Chromocell to Present at Sidoti Virtual Investor Conference March 13-14	11.03.
Chromocell to Present at Sidoti Virtual Investor Conference March 13-14	11.03.
Benuvia Operations, LLC and Chromocell Therapeutics Corp. Announce Strategic Partnership to Advance Healthcare Solutions	27.02.
Chromocell Therapeutics Announces Closing of Initial Public Offering for Gross Proceeds of $6.6 Million	21.02.
Chromocell Therapeutics Corporation has completed an IPO in the amount of $6.6 million.	15.02.
Chromocell Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	16.01.
Chromocell Therapeutics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	01.09.23
Chromocell Therapeutics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	30.06.23
Chromocell Therapeutics Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	01.05.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Börse
Aktien
A3DXS6 Aktie
Nachrichten Chromocell Therapeutics Corporation
Andere Sprachen

Sichern und steigern Sie die Performance Ihrer Investitionen - mit unserem Expertenteam an Ihrer Seite.

Meine Investitionen sichern

fermer